Sign In
Buy SAVA
$1.96
+0 (+0%)
At Close: Jun 03, 2026
Better Biotech Stock: Cassava Sciences vs. Annovis Bio
05:49am, Thursday, 26'th Aug 2021
It boils down to which company's clinical trial results look better for treating Alzheimer's at the moment.
LOS ANGELES--(BUSINESS WIRE)---- $SAVA #SAVA--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cassava Sciences, Inc.
LOS ANGELES--(BUSINESS WIRE)---- $SAVA #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a national investor rights law firm, continues its investigation on behalf of Cassava Sciences, Inc. (“C
Cassava Investor Alert
05:58pm, Wednesday, 25'th Aug 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Cassava To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Co
The Law Offices of Frank R. Cruz Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
05:00pm, Wednesday, 25'th Aug 2021
LOS ANGELES--(BUSINESS WIRE)---- $SAVA #investors--The Law Offices of Frank R. Cruz Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Cassava Sciences, Inc. (SAVA) on Behalf of Investors
03:00pm, Wednesday, 25'th Aug 2021
BENSALEM, Pa.--(BUSINESS WIRE)---- $SAVA #CLASSACTION--Law Offices of Howard G. Smith continues its investigation on behalf of Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA
SAVA Stock: Cassava Sciences Sinks Despite Countering Trial Data Allegations
02:54pm, Wednesday, 25'th Aug 2021
Today, investors in Cassava Sciences and SAVA stock are seeing a lot of red, as investors digest a statement of concern filed yesterday. The post SAVA Stock: Cassava Sciences Sinks Despite Countering
SHAREHOLDER ALERT: Investigation of Cassava Sciences, Inc. Announced by Holzer & Holzer, LLC
01:42pm, Wednesday, 25'th Aug 2021
Atlanta, Georgia--(Newsfile Corp. - August 25, 2021) - Holzer & Holzer, LLC is investigating whether Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA) complied with federal securities
2 Little-Known Nasdaq Stocks Making Big Moves Wednesday
01:10pm, Wednesday, 25'th Aug 2021
Don't let these companies fly under your radar.
LOS ANGELES--(BUSINESS WIRE)---- $SAVA #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on
Shareholder Alert: Berman Tabacco Announces Investigation of Cassava Sciences, Inc. (SAVA) for Potential Securities Law Violations
11:00am, Wednesday, 25'th Aug 2021
Boston, Massachusetts--(Newsfile Corp. - August 25, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Cassava Sciences, Inc. (
7 Bargain Stocks to Buy Under $5 With the Right Catalysts
10:58am, Wednesday, 25'th Aug 2021
The risk in these inexpensive bargain stocks is offset by their upside for investors looking for a little more spice in their portfolio. The post 7 Bargain Stocks to Buy Under $5 With the Right Cataly
Here's why Cassava Sciences stock tanked 30% Wednesday morning
10:34am, Wednesday, 25'th Aug 2021
Cassava Sciences Inc (NASDAQ: SAVA) reached an SPA (Special Protocol Assessment) agreement with the U.S. FDA on Tuesday morning for the phase 3 trial of its Alzheimer's treatment, Simufilam. Shares of
Cassava Sciences Stock Shows Promise With Simufilam Trials Drawing Near
10:03am, Wednesday, 25'th Aug 2021
SAVA stock is up as the company announced the FDA has agreed on study protocols for Phase 3 clinical trials of Simufilam. The post Cassava Sciences Stock Shows Promise With Simufilam Trials Drawing Ne
Cassava Sciences Shares Sink With Alzheimer's Drug Mired In Controversy
08:49am, Wednesday, 25'th Aug 2021
Neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) saw both sides of the world Tuesday. The stock rallied to close higher by 2% after it announced an agreement with the
